Seganserin

DB19608ExperimentalSmall molecule

Seganserin is a small molecule drug. The usage of the INN stem '-anserin' in the name indicates that Seganserin is a serotonin receptor antagonist. Seganserin has a monoisotopic molecular weight...

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2C, and 5-hydroxytryptamine receptor 2
Curator reviewed
Formula / weight: C₂₉H₂₇F₂N₃O · 471.552 g/mol (avg)

Resolves to

Compound

UNII197HL4EZCCCAS87729-89-3ChEMBLCHEMBL1742436ChEBI750032PubChem71767

Structure

InChIKeyZGUPMFYFHHSNFK-UHFFFAOYSA-NSMILESCC1=C(CCN2CCC(CC2)=C(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)C(=O)N2C=CC=CC2=N1

Targets

P28223HTR2AP28335HTR2C

What you can answer from here — as of September 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Seganserin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account